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We conducted a genome-wide analysis of variations in guanine plus cytosine (G+C) 
content at the third codon position at silent substitution sites of orthologous human and 
mouse protein-coding nucleotide sequences. Alignments of 3,776 human protein-coding 
DNA sequences with mouse orthologs having more than 50 synonymous codons were 
analyzed, and nucleotide substitutions were counted by comparing sequences in the 
alignments extracted from gap-free regions. The G+C content at silent sites in these pairs of 
genes showed a strong negative correlation (r = -0.93). Some gene pairs showed significant 
differences in G+C content at the third codon position at silent substitution sites. For 
example, human thymine-DNA glycosylase was A+T-rich at the silent substitution sites, 
while the orthologous mouse sequence was G+C-rich at the corresponding sites. In contrast, 
human matrix metalloproteinase 23B was G+C-rich at silent substitution sites, while the 
mouse ortholog was A+T-rich. We discuss possible implications of this significant negative 
correlation of G+C content at silent sites. 
 




The availability of complete mammalian genome sequences1-4 provides an opportunity 
to characterize nucleotide substitution patterns among mammalian genomes by comparative 
sequence analysis.5-11 The G+C content in bacterial genomes varies among species from 25% 
to 75%, but it is relatively homogeneous for genes within a given bacterial genome.12-13 
However, the G+C content of genes in a given mammalian genome varies considerably, 
because mammalian genomes are a mosaic of long (over hundreds of kilobases) DNA 
segments known as isochores.14 Some G+C-poor isochores have G+C contents as low as 
35%, while G+C-rich isochores have G+C contents as high as 60%. It is known that the 
genes within a given isochore are fairly homogeneous in G+C content. It has been reported 
that some homologous mammalian genes that occupy different chromosomal positions differ 
considerably in their base composition and codon usage.14-16 Human α- and β-globin genes 
are an example of this position-dependent variation. The α-globin gene cluster occupies a 
G+C-rich region, while the β-globin gene resides in a G+C-poor region.14 
In comparing alignments of orthologous human and mouse sequences, we noted that 
silent substitution sites at the third codon position were biased toward G+C-rich or A+T-rich 
nucleotides. For example, human thymine-DNA glycosylase was A+T-rich at silent 
substitution sites, while the orthologous mouse sequence was G+C-rich at the corresponding 
sites. However, human matrix metalloproteinase 23B was G+C-rich at silent substitution 
sites, whereas the mouse ortholog was A+T-rich at those sites. Since complete human and 
mouse genome sequences are now available, we conducted a comparative genome-wide 
analysis of G+C content variation at silent substitution sites in orthologous human and 
mouse sequences. 
 
1. Correlation of G+C content at the third codon position at silent substitution sites 
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The G+C content at the third codon position in synonymous codons, i.e., silent 
substitutions of the same amino acid, was determined for both human and mouse sequences. 
For simplicity, only synonymous codons that had an identical nucleotide at the first codon 
position were considered. The G+C contents at the third codon position at silent substitution 
sites in the 3,776 pairs of human and mouse genes are plotted in Figure 1, showing a high 
negative correlation (r = -0.93). The plot indicates distinct variations in G+C content at 
mutual silent sites in many human and mouse orthologs.  
--------- Figure 1 here -------- 
In two-fold degenerate codons, the equivalent third position nucleotides are either two 
purines (A/G) or two pyrimidines (C/T). Therefore, their silent substitutions always result in 
G+C content variation. However, not every silent substitution in four-fold degenerate codons 
yields G+C content variation. To further examine G+C content correlation at silent 
substitution sites, the G+C contents in four-fold degenerate codons were analyzed. The G+C 
contents at silent substitution sites were determined for the eight sets of four-fold degenerate 
codons (Ala: GCN, Arg: CGN, Gly: GGN, Leu: CUN, Pro: CCN, Ser: UCN, Thr: ACN, and 
Val: GUN) in human and mouse sequences. The plot of the G+C contents in four-fold 
degenerate sites between 2,084 human and mouse orthologous sequences having more than 
50 four-fold degenerate codons had a high negative correlation coefficient (r = -0.82; data 
not shown). 
 
2. Classification of orthologous sequences according to G+C content at the third codon 
position at silent substitution sites 
Human and mouse orthologous sequence pairs were divided into three groups according 
to the G+C content at the third codon position in synonymous substitution sites. In group (a), 
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the human gene had a much lower G+C content than that in the mouse gene, in group (b) the 
human gene had a much higher G+C content than that in the mouse gene, and in group (c) 
the human gene had a G+C content similar to that in the mouse gene. The number of genes in 
the three groups varied according to the criterion of the classification. Using a cutoff of 30% 
lower G+C content in the human gene than in the mouse, 25.4% (960/3776) of the 
orthologous sequence pairs were classified in group (a). Based on 30% higher G+C content 
in the human gene than in the mouse gene, group (b) contained 17.2% (648/3776) of the 
orthologous sequence pairs. Group (c) contained the remaining 57.4% (2168/3776) of 
sequence pairs, which showed deviations between -30% and +30% in G+C content when 
human and mouse orthologous sequences were compared. Table 1 lists the proteins encoded 
by 10 well-characterized genes in each of the three groups. Most of the gene pairs within 
groups (a), (b), and (c) had different chromosomal locations. However, some genes within 
the same group had the same chromosomal locations. For example, in group (a), human 
potassium channel tetramerization domain containing protein 3 and human ribosomal protein 
S6 kinase are both located on human chromosome 1q41, and both of the corresponding 
mouse genes are on mouse chromosome 1H6. In group (b), human agrin, human calcium 
binding protein Cab45 precursor, and human matrix metalloproteinase 23B are all located on 
human chromosome 1p36.33, and the corresponding mouse genes are on mouse chromosome 
4E2. These findings suggest that the G+C content at some silent substitution sites might be 
determined by their chromosomal locations. This finding is consistent with the report by 
Bernardi et al.14  
--------- Table 1 here -------- 
 
3. Frequencies of substitution 
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The parts of the alignments for thymine-DNA glycosylase (human gene: NM_003211.3 and 
mouse gene: NM_011561.1) and for matrix metalloproteinase 23B (human gene: 
NM_006983.1and mouse gene: NM_011985.1) are shown in Figure 2(a) and (b), 
respectively. In Figure 2, nucleotides A and T at silent substitution sites are red, nucleotides 
G and C at silent substitution sites are blue, and other nucleotides are shown in yellow. 
Amino acids are shown along the DNA sequences.  
--------- Figure 2 (a) and (b) here -------- 
Nucleotide substitutions were observed in 14% (738,506/5,401,758) of all of the total 
nucleotides contained within the 3,776 pairs of orthologous human and mouse genes. 
Substitution frequencies in codons were 18% at the first position, 12% at the second, and 70% 
at the third. Silent nucleotide substitutions with an identical nucleotide at the first codon 
position accounted for 58% (425,945/738,506) of the total substitutions. The substitution 
frequency of transitions (purine-purine and pyrimidine-pyrimidine substitutions) was 66.1%, 
and that of transversions (purine-pyrimidine and pyrimidine-purine substitutions) was 33.9%. 
Transitions accounted for 72.1%, and transversions for 27.9%, of the total silent nucleotide 
substitutions. Transitions were more frequent than transversions at silent substitutions because 
transitions at the third codon position are essentially silent.  
When a silent substitution was observed at an alignment site, a silent nucleotide 
substitution was assumed to occur once in either branch at a synonymous codon site since the 
divergence of human and mouse lineage. Silent substitutions at synonymous codon sites 
between human and mouse sequences were estimated. Nucleotide substitutions were 
considered from the human sequence. The frequencies of the four nucleotides A, T, C, and G 
at the third codon position at silent substitution sites in human sequence were expressed as 
f(A), f(T), f(C), and f(G). Let α and β be the transition and the transversion substitution rate 
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per year per site. T indicates the divergence time between human and mouse. Then, the 
nucleotide substitution frequencies at silent sites from human to mouse were calculated as 
shown in Table 2. Substitution frequency at G or C nucleotide in human silent sites is 
2T(α+2β)⋅(f(G)+f(C)), and that in mouse silent sites is 2T(α+β)⋅(f(A)+f(T))+ 2Τβ⋅(f(G)+f(C)), 
which is equivalent to 2T(α+β)-2Tα⋅(f(G)+f(C)). The above nucleotide substitution 
frequencies were expressed as X and Y, respectively. 
X = 2T(α+2β)⋅(f(G)+f(C)) 
Y = 2T(α+β)-2Tα⋅(f(G)+f(C)) 
The relationship between X and Y is  
Y =2T (α+β)-{α/(α+2β)}⋅X  
This equation indicates that Y increases when X decreases and Y decreases when X increases. 
This result indicated a negative correlation in the variation of G+C content at silent sites 
between the two DNA sequences. 
--------- Table 2 here -------- 
 
4. The implications of substitutions at silent sites 
Because substitutions at silent sites in codons do not change amino acids, no effect on 
proteins would be expected, and these substitutions are commonly thought of as being 
evolutionarily neutral. However, substitutions at silent sites do alter codon usage. Grantham 
reported that synonymous codons are used differently by different organisms,18 and Ikemura 
found a strong positive correlation between codon usage and tRNA content in unicellular 
organisms.19 The codon-choice patterns of genes are often very different among multicellular 
eukaryotes, and codon usage in mammals is known to have dramatic effects on the translation 
rate.20 Our findings on the differential codon usage between human and mouse genes suggest 
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the possibility of different expression patterns. 
Evidence indicates that genes with a high G+C content at the third codon position are 
usually surrounded by long G+C-rich genomic sequences, while those with a low G+C 
content at the third position are usually surrounded by long A+T-rich sequences.19,21 
Human-mouse genome sequence comparisons demonstrated a large number of 
rearrangements of conserved syntenic segments. 2,22 Since human and mouse genomes exhibit 
large variations in G+C content (e.g., isochores),14 the rearrangements might produce a large 
deviation in G+C content between human and mouse genes by changing the surrounding 
sequences. The gene pairs classified into groups (a) and (b), which showed a large variation in 
G+C content at silent substitution sites, are considered to be products of the rearrangements of 
syntenic segments. The genes located in an identical syntenic segment exhibited similar G+C 
content variation. Gene rearrangements could be the cause of large variations in G+C content 
at silent substitution sites, and might lead to a significant negative correlation. 
Nucleotide substitutions between human and mouse sequences have accumulated during 
evolution ever since their divergence from a common ancestor. It is generally assumed that 
the substitutions occurred independently in the two species, and there would seem to be no 
connection between the silent nucleotide substitutions in humans and mice. The results of this 
study raise the question of whether correlated substitutions at silent sites might have some 
possible evolutionary function. Further study is needed to address this issue. 
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Table 1. Variations in G+C content at the third codon position in synonymous substitution sites (G+C III) for protein-coding genes. 
The length, the percentage of nucleotide sequence identity, the G+C content of the entire alignment, and chromosomal locations 
for human and mouse are shown.
(a) G+C III content: human << mouse 
entire alignment synonymous codons
No.  gene product length identity G+C (%) chromosomal location G+C III (%)
nucleotides (%) human mouse human mouse No. human mouse
1. cytidine monophosphate N-acetylneuraminic acid synthetase 1203 88.0 43.1 49.9 12p12.1 6G2 106 19.8 84.0
2. DNA helicase HEL308 849 80.8 40.6 50.1 4q21.23 5E4 83 18.1 80.7
3. DNA primase large subunit, 58kDa 1515 84.4 41.4 48.6 6p12 1B 136 19.9 80.2
4. dolichyl phosphate glucosyltransferase 900 87.2 41.2 48.0 13q13.3 3C 71 15.5 81.7
5. geranylgeranyltransferase type I, beta subunit 1131 87.1 44.4 51.6 5q22.3 18C 119 18.5 79.0
 6. phosphatidylinositol glycan, class B mannose transferase 1482 80.2 38.7 50.0 15q21 9D 126 12.7 86.5
7. phosphoinositide-3-kinase, regulatory subunit 4, p150 3477 85.3 42.5 51.8 3q21.3 9F1 389 15.2 82.5
8. potassium channel tetramerization domain containing protein 1815 83.3 43.4 54.8 1q41 1H6 225 12.4 83.1
9. ribosomal protein S6 kinase, 52kDa, polypeptide 1 990 80.6 44.0 56.1 1q41 1H6 88 14.8 85.2
10. thymine-DNA glycosylase 915 85.8 40.2 48.5 12q24.1 10C1 102 19.6 85.3
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(b) G+C III content: human >> mouse
entire alignment synonymous codons
No.  gene product length identity G+C (%) chromosomal location G+C III (%)
nucleotides (%) human mouse human mouse No. human mouse
1. agrin (neuronal aggregation factor) 2448 80.2 69.0 58.7 1p36.33 4E2 270 81.9 23.0
2. calcium binding protein Cab45 precursor 1074 82.8 60.6 51.5 1p36.33 4E2 103 85.4 24.3
3. galactose-3-O-sulfotransferase 2 657 74.1 69.0 54.8 2q37.3 1D 54 96.3 31.5
4. alpha-L-iduronidase precursor 1827 80.2 67.9 56.7 4p16.3 5E5 164 87.2 21.3
5. matrix metalloproteinase 23B 996 81.6 68.7 56.1 1p36.33 4E2 104 93.3 13.5
6. methyl-CpG binding domain protein 3 801 89.1 65.2 58.8 19p13.3 10C1 73 86.3 20.6
7. N-methyl D-aspartate receptor 1 isoform NR1-3 2814 90.7 60.8 55.8 9q34.3 2A3 235 81.3 24.7
8. plakophilin 3 2391 86.4 67.3 60.5 11p15 7F5 216 83.8 21.3
9. prostaglandin E receptor 1 subtype EP1 642 80.7 76.6 65.6 19p13.1 8C2 75 89.3 29.3
10. renin binding protein 1200 85.2 61.5 53.8 Xq28 XA7.3 92 82.6 22.8
(c) G+C III content: human ≈ mouse
entire alignment synonymous codons
No.  gene product length identity G+C (%) chromosomal location G+C III (%)
nucleotides (%) human mouse human mouse No. human mouse
1. apolipoprotein B 5394 82.3 46.8 46.9 2p24 12A1 365 49.0 47.7
2. dihydrolipoamide S-succinyltransferase 1203 88.2 51.3 51.6 14q24.3 12D3 88 47.7 47.7
3. 5'-3' exoribonuclease 2 2736 91.9 43.9 44.2 20p11.2 2H1 146 45.9 45.2
4. glutathione synthetase 1422 88.3 56.4 55.3 20q11.2 2H1 87 50.6 50.6
5. 5-hydroxytryptamine (seretonin) receptor 3B 1263 80.1 50.5 50.9 11q23.1 9B 92 50.0 48.9
6. ornithine carbamoyltransferase 1062 88.9 44.1 44.9 Xp21.1 XA1 70 48.6 48.6
7. polymerase (DNA directed), alpha 3270 90.8 41.7 40.5 Xp22.1 XC 154 47.4 48.1
8. transaldolase 1 1011 88.1 54.9 55.0 11p15.5 7F3 81 54.3 55.6
9. triosephosphate isomerase 1 747 88.6 56.6 55.7 12p13 6F2 68 52.9 52.9
10. ubiquitin protein ligase E3C 3249 87.3 45.9 46.1 7q36.3 5B1 265 50.2 49.8
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Table 2. Rates of nucleotide substitution.
mouse nucleotide
human nucleotide A T C G
A 2T βf(A) 2T βf(A) 2T αf(A)
T 2T βf(T) 2T αf(T) 2T βf(T)
C 2T βf(C) 2T αf(C) 2T βf(C)





Figure 1.  
G+C contents at silent sites in 3,776 human protein-coding sequences versus G+C contents 
at silent sites in 3,776 corresponding mouse sequences. The human and mouse cDNA 
sequences were obtained from Reference Sequence Release 11 from the U.S. National Center 
for Biotechnology Information (ftp://ftp.ncbi.nih.gov/refseq/). The protein-encoding 
nucleotide sequences were selected according to the feature table for the data. The amino 
acid sequences of 28,893 human cDNAs and 25,298 mouse cDNAs were obtained by 
translation. Orthologs were identified by the two-directional best hit approach using 
BLASTP.17 Pairs of a given sequence were selected if they showed greater than 30% amino 
acid identity over three-fourths of the total length. To avoid bias, proteins showing greater 
than 30% sequence identity with other proteins in the same species were excluded. Gap-free 
alignment regions longer than 100 amino acid residues and the corresponding DNA 
sequences were analyzed. Based on this criterion, 3,776 pairwise alignments of human and 
mouse sequences that had more than 50 synonymous codons were chosen for analysis in this 
study. 
 
Figure 2  
Panels (a) and (b) show the alignment between sequences of human and mouse 
thymine-DNA glycosylase, and alignment of human and mouse sequences of matrix 
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Fig. 2(a), (b)  
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GGAAG AAAAG AAACCCAGAACAACAGA CC AAACAACCAGTGGA CCCAAAAAACCTGTTGAGTC AA
mouse  AAGAGAAGGAAAAGGAAACCCAGAGCAGCAGAGCCCCAGGAACCAGTGGAGCCCAAAAAACCTGCTACGTCGAAG 
        K R R K R K P R A A E P Q E P V E P K K P A T S K 
 
        K S G K S A K S K E K Q E K I T D T F K V K R K V  50 
human  AAATC GGCAAGTCTGCAAAATCAAA GAAAA CA GA AAAAT ACAGACACATTTAAAGT AAAAG AAAGT
mouse  AAATCCGGCAAGTCTACAAAATCAAAGGAAAAGCAGGAGAAAATCACAGACGCGTTTAAAGTGAAAAGGAAAGTG 
        K S G K S T K S K E K Q E K I T D A F K V K R K V 
 
        D R F N G V S E A E L L T K T L P D I L T F N L D  75 
human  GACCG TT AA GG GT TC GAAGCTGA CTTCTGACCAAGACTCTCCCCGA ATTTTGACCTTCAATCTGGAC 
mouse  GACCGCTTCAACGGCGTCTC GAAGCTGAGCTTCTGACCAAGACTCT CC GACATTTTGACCTTCAATCTGGA
        D R F N G V S E A E L L T K T L P D I L T F N L D 
 
        I V I I G I N P G L M A A Y K G H H Y P G P G N H 100 
human  ATTGTCAT ATTGGCAT AACCCGGGACTAATGGCTGCTTACAAAGGGCATCA TACCCTGG CCTGGAAACCA
mouse  ATTGTGATCATTGGCAT AACCCGGGATTAATGGCTGCTTACAAAGG CATCACTACCCTGGGCCTGGAAA CAC 
        I V I I G I N P G L M A A Y K G H H Y P G P G N H 
 
        F W K C L F M S G L S E V Q L N H M D D H T L P G 125 
human  TT TGGAAGTGTTTGTT ATGTC GGGCTCAGTGAGGTCCAGCTGAACCA ATGGATGA CACAC CTACC GGG 
mouse  TTCTGGAAGTGTCTGTTCATGTCGGGGCTGAGTGAGGTGCAGCTGAA CACATGGATGACCACACCTTACCCGGC 
        F W K C L F M S G L S E V Q L N H M D D H T L P G 
 
        K Y G I G F T N M V E R T T P G S K D L S S K E F 150 
human  AAGTA GG AT GGATT ACCAACATGGTGGAAAGGACCACGCCCGGCAGCAA GATCTCTCCAGTAAAGA TT
mouse  AAGTACGGCATCGGATTCACCAACATGGTGGAACGGACGACGCCGGGCAGCAAGGATCTGTC AGTAAAGAGTTC 






        A  P  E  Q  P  S  D  L  R  I  G  F  Y  P  I  N  H  T  D  C  L  V  S  A  L   25 
human  GCCCCCGAGCAGCCCAGCGACCTCCGGATAGGCTTCTACCCGATCAACCACACGGACTGCCTGGTCTCCGCGCTG 
mouse  GCCCC GA CGTCCCAG GACCTCAAGATAGG TTCTACCC GTCAACCACACCGACTGCTTGGTCTC GC GTG 
        A  P  E  R  P  S  D  L  K  I  G  F  Y  P  V  N  H  T  D  C  L  V  S  A  V 
 
        H  H  C  F  D  G  P  T  G  E  L  A  H  A  F  F  P  P  H  G  G  I  H  F  D   50 
human  CACCACTGCTTCGACGGCCCCACGGGGGAGCTGGCCCACGCCTTCTTCCCCCCGCACGGCGGCATCCACTTCGAC 
mouse  CACCACTGCTT GA GG CCCAC GG GA CTGGCCCACGC TTCTTCCC CCCCACGG GGCAT CACTT GA
        H  H  C  F  D  G  P  T  G  E  L  A  H  A  F  F  P  P  H  G  G  I  H  F  D 
 
        D  S  E  Y  W  V  L  G  P  T  R  Y  S  W  K  K  G  V  W  L  T  D  L  V  H   75 
human  GACAGCGAGTACTGGGTCCTGGGCCCCACGCGCTACAGCTGGAAGAAAGGCGTGTGGCTCACGGACCTGGTGCAC 
mouse  GACAGCGAGTACTGGGTCTTGGGCCCCAC CGCTACAG TGGAAGAAAGG GT TGGCTCAC AACCTGGTGCAC 
        D  S  E  Y  W  V  L  G  P  T  R  Y  S  W  K  K  G  V  W  L  T  N  L  V  H 
 
        V  A  A  H  E  I  G  H  A  L  G  L  M  H  S  Q  H  G  R  A  L  M  H  L  N  100 
human  GTGGCGGCCCACGAGATCGGCCACGCGCTGGGCCTGATGCACTCACA CACGGCCGGGCGCTCATGCACCTGAAC 
mouse  GTGGC GCCCA GAGAT GGCCA GC CTGGGCCTGATGCACTCACAGCAAGATCAGGCGCTCATGCACCTCAA
        V  A  A  H  E  I  G  H  A  L  G  L  M  H  S  Q  Q  D  Q  A  L  M  H  L  N 
 
        A  T  L  R  G  W  K  A  L  S  Q  D  E  L  W  G  L  H  R  L  Y  G  C  L  D  125 
human  GCCACGCTGCGCGGCTGGAAGGCGTTGTCCCAGGACGAGCTGTGGGGGCTGCACCGGCTCTACGG TGCCTCGAC 
mouse  GCCAC TTGCG GGCTGGAAGGC CTGTCCCAGGA GA CTGTGGGGGTTACACCG CTCTA GGCTGCCTGGAC 
        A  T  L  R  G  W  K  A  L  S  Q  D  E  L  W  G  L  H  R  L  Y  G  C  L  D 
 
        R  L  F  V  C  A  S  W  A  R  R  G  F  C  D  A  R  R  R  L  M  K  R  L  C  150 
human  AGGCTGTTCGTGTGCGCGTCCTGGGCGCGGAGGGGCTTCTGCGACGCTCGCCGGCGGCTCATGAAGAGGCTCTGC 
mouse  CGGATTTT GTGTG GC TCCTGGGC CG AAGGG TT TG GA GTCCGCCAGAGGCTCATGAAGAGGCTCTGC 
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